Like MM PCs from patients, 5TGM1 PCs produce a monoclonal antibody (paraprotein or M-protein) that can readily be detected in peripheral blood using serum protein electrophoresis (SPEP) analysis, with quantitation of paraprotein providing an assessment of total body tumor burden. This evidence concerns the gene MYOM2 and Miyoshi myopathy.